PCAS is celebrating in 2012 its 50th Anniversary in custom manufacturing and API production for the life sciences industry. PCAS has 750m3 capacity for producing active pharmaceutical ingredients and advanced intermediates. PCAS, a full range of services for the Pharmaceutical Industry, has: - 5 R&D Units for synthesis - 125 Scientists. - 4 plants ISO 9001 (400m3) for chemical intermediates. - 4 plants cGMP (350m3) for APIs production and a cGMP Kilolab in Santa Rosa, CA for clinical and commercial APIs. PCAS' areas of special expertise: Biocatalysis development, 20m3 of cGMP capacity available for cryogenic reactions (-90C), combined with organometallic reagents that support part of our special expertise in chiral synthesis. PLGA polymers for sustained release formulation. Acrolein and bromine chemistry. Thiophene and phosphorous derivatives. Regulatory Affairs Expertise. PCAS' Other activities: Aroma chemicals, Organic intermediates, Industrial speciality chemicals, Fine mineral chemicals, Photochemicals & electronics.